Alerts will be sent to your verified email
Verify Email
AAREYDRUGS
|
Aarey Drugs & Pharma
|
Oxygenta Pharma
|
Syschem (India)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.07 % | 10.1 % | -15.43 % |
|
5yr average Equity Multiplier
|
2.28 | -1.22 | 5.54 |
|
5yr Average Asset Turnover Ratio
|
1.56 | 1.1 | 1.2 |
|
5yr Avg Net Profit Margin
|
1.44 % | -16.74 % | -1.1 % |
|
Price to Book
|
1.62 | 0.0 | 2.72 |
|
P/E
|
53.99 | 0.0 | 124.15 |
|
5yr Avg Cash Conversion Cycle
|
77.34 Days | -56.32 Days | 2.82 Days |
|
Inventory Days
|
20.31 Days | 94.46 Days | 86.99 Days |
|
Days Receivable
|
172.65 Days | 80.66 Days | 74.65 Days |
|
Days Payable
|
98.9 Days | 174.19 Days | 168.44 Days |
|
5yr Average Interest Coverage Ratio
|
4.14 | -3.11 | 8.6 |
|
5yr Avg ROCE
|
8.93 % | -80.86 % | -1.51 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | -18.99 % | 1.15 % |
|
5 yr average Debt to Equity
|
0.21 | -1.55 | 0.49 |
|
5yr CAGR Net Profit
|
-4.17 % | -9.68 % | n/a |
|
5yr Average Return on Assets
|
2.26 % | -10.42 % | -0.74 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.8 % | 57.95 % | 56.71 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.23 % | 45.62 % | 34.93 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.04 % | 0.0 |
|
Aarey Drugs & Pharma
|
Oxygenta Pharma
|
Syschem (India)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|